The risk or severity of adverse effects can be increased when Azelnidipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Lovastatin is combined with Atorvastatin. The serum concentration of Amodiaquine can be increased when it is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Ixazomib. The serum concentration of Atorvastatin can be decreased when it is combined with Dabrafenib. The serum concentration of Atorvastatin can be increased when it is combined with Voriconazole. The risk or severity of adverse effects can be increased when Atorvastatin is combined with Ketoconazole. The risk or severity of adverse effects can be increased when Perhexiline is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Antithrombin III human. The risk or severity of adverse effects can be increased when Oxymetholone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Benidipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Topiroxostat is combined with Atorvastatin. The serum concentration of Prucalopride can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Cisapride is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Betamethasone is combined with Atorvastatin. Raltegravir may increase the myopathic rhabdomyolysis activities of Atorvastatin. The risk or severity of adverse effects can be increased when Dexamethasone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Cinnarizine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Etoposide is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with GM6001. The serum concentration of Atorvastatin can be increased when it is combined with Delanzomib. The serum concentration of Atorvastatin can be increased when it is combined with Gabexate. The risk or severity of adverse effects can be increased when Elbasvir is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Abiraterone. The risk or severity of adverse effects can be increased when Valproic Acid is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Tranilast is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Magaldrate. The serum concentration of Atorvastatin can be decreased when it is combined with Tromethamine. The serum concentration of Atorvastatin can be decreased when it is combined with Aluminium. The risk or severity of adverse effects can be increased when Isoniazid is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Amprenavir. The risk or severity of adverse effects can be increased when Bicalutamide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Salbutamol is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Progesterone is combined with Atorvastatin. The metabolism of Atorvastatin can be increased when combined with Rifapentine. The serum concentration of Atorvastatin can be increased when it is combined with Lisinopril. The serum concentration of Atorvastatin can be increased when it is combined with Ribociclib. The serum concentration of Lanthanum carbonate can be decreased when it is combined with Atorvastatin. Atorvastatin may increase the anticoagulant activities of Acenocoumarol. The serum concentration of Atorvastatin can be increased when it is combined with Trandolapril. The risk or severity of adverse effects can be increased when Troglitazone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Modafinil is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Sildenafil is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Cyclophosphamide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Felodipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Cilnidipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ziconotide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ciprofloxacin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Caffeine is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Bexarotene. The serum concentration of Atorvastatin can be decreased when it is combined with Almasilate. The risk or severity of adverse effects can be increased when Kitasamycin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Rosuvastatin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Methysergide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Propofol is combined with Atorvastatin. Atorvastatin may increase the hypoglycemic activities of Glipizide. The serum concentration of Atorvastatin can be decreased when it is combined with Tocilizumab. The risk or severity of adverse effects can be increased when Temsirolimus is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Zofenopril. The serum concentration of Atorvastatin can be increased when it is combined with Racecadotril. Azithromycin may increase the myopathic rhabdomyolysis activities of Atorvastatin. The serum concentration of Mevastatin can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Troleandomycin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Aldesleukin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Abafungin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Delavirdine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Batimastat. The risk or severity of adverse effects can be increased when Docetaxel is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Glyburide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Methylergometrine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Ranolazine. The risk or severity of adverse effects can be increased when Ethanol is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Perindopril. The risk or severity of adverse effects can be increased when Ceritinib is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Nicergoline is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Levosalbutamol is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Cocaine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Terfenadine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Pilocarpine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Fosaprepitant is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Levofloxacin is combined with Atorvastatin. Atorvastatin may increase the hypoglycemic activities of Glibornuride. The risk or severity of adverse effects can be increased when Prednisolone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Butoconazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Netupitant is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Quinupristin is combined with Atorvastatin. Atorvastatin may increase the anticoagulant activities of Phenprocoumon. The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Teriflunomide. The serum concentration of Atorvastatin can be increased when it is combined with Boceprevir. The serum concentration of Silodosin can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Metronidazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Clozapine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Lapatinib is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Metyrapone is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Apixaban. Atorvastatin may increase the anticoagulant activities of Dicoumarol. The risk or severity of adverse effects can be increased when Tacrolimus is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Saxagliptin. The risk or severity of adverse effects can be increased when Alprazolam is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Buprenorphine is combined with Atorvastatin. Atorvastatin may increase the anticoagulant activities of Fluindione. The serum concentration of Vincristine can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Vinblastine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Sivelestat. The metabolism of Atorvastatin can be decreased when combined with Amiodarone. The serum concentration of Atorvastatin can be increased when it is combined with Fusidic Acid. The risk or severity of adverse effects can be increased when Amlodipine is combined with Atorvastatin. Atorvastatin may increase the hypoglycemic activities of Gliquidone. The risk or severity of adverse effects can be increased when Ergotamine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Mirtazapine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Argatroban. The risk or severity of adverse effects can be increased when Pimozide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Olaparib is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Asunaprevir. The risk or severity of adverse effects can be increased when Glycerol Phenylbutyrate is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Xylometazoline is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Vinorelbine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Repaglinide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Nimodipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Epinephrine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Cholesterol. Atorvastatin may increase the hypoglycemic activities of Glimepiride. The serum concentration of Atorvastatin can be increased when it is combined with Ritonavir. The serum concentration of Atorvastatin can be increased when it is combined with Temocapril. The metabolism of Atorvastatin can be increased when combined with Pentobarbital. The serum concentration of Atorvastatin can be increased when it is combined with Ombitasvir.